These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 19384282)
1. Comparative molecular docking of antitrypanosomal natural products into multiple Trypanosoma brucei drug targets. Ogungbe IV; Setzer WN Molecules; 2009 Apr; 14(4):1513-36. PubMed ID: 19384282 [TBL] [Abstract][Full Text] [Related]
2. In Silico Identification and in Vitro Activity of Novel Natural Inhibitors of Trypanosoma brucei Glyceraldehyde-3-phosphate-dehydrogenase. Herrmann FC; Lenz M; Jose J; Kaiser M; Brun R; Schmidt TJ Molecules; 2015 Sep; 20(9):16154-69. PubMed ID: 26404225 [TBL] [Abstract][Full Text] [Related]
3. Discovery of a quinoline-based phenyl sulfone derivative as an antitrypanosomal agent. Zhang H; Collins J; Nyamwihura R; Ware S; Kaiser M; Ogungbe IV Bioorg Med Chem Lett; 2018 May; 28(9):1647-1651. PubMed ID: 29609908 [TBL] [Abstract][Full Text] [Related]
4. Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi. Belluti F; Uliassi E; Veronesi G; Bergamini C; Kaiser M; Brun R; Viola A; Fato R; Michels PA; Krauth-Siegel RL; Cavalli A; Bolognesi ML ChemMedChem; 2014 Feb; 9(2):371-82. PubMed ID: 24403089 [TBL] [Abstract][Full Text] [Related]
5. Investigation of trypanothione reductase as a drug target in Trypanosoma brucei. Spinks D; Shanks EJ; Cleghorn LA; McElroy S; Jones D; James D; Fairlamb AH; Frearson JA; Wyatt PG; Gilbert IH ChemMedChem; 2009 Dec; 4(12):2060-9. PubMed ID: 19924760 [TBL] [Abstract][Full Text] [Related]
6. Crassiflorone derivatives that inhibit Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase (TbGAPDH) and Trypanosoma cruzi trypanothione reductase (TcTR) and display trypanocidal activity. Uliassi E; Fiorani G; Krauth-Siegel RL; Bergamini C; Fato R; Bianchini G; Carlos Menéndez J; Molina MT; López-Montero E; Falchi F; Cavalli A; Gul S; Kuzikov M; Ellinger B; Witt G; Moraes CB; Freitas-Junior LH; Borsari C; Costi MP; Bolognesi ML Eur J Med Chem; 2017 Dec; 141():138-148. PubMed ID: 29031061 [TBL] [Abstract][Full Text] [Related]
7. In Vitro and In Vivo Investigation of the Inhibition of Trypanosoma brucei Cell Growth by Lipophilic Bisphosphonates. Yang G; Zhu W; Kim K; Byun SY; Choi G; Wang K; Cha JS; Cho HS; Oldfield E; No JH Antimicrob Agents Chemother; 2015 Dec; 59(12):7530-9. PubMed ID: 26392508 [TBL] [Abstract][Full Text] [Related]
9. Ebsulfur is a benzisothiazolone cytocidal inhibitor targeting the trypanothione reductase of Trypanosoma brucei. Lu J; Vodnala SK; Gustavsson AL; Gustafsson TN; Sjöberg B; Johansson HA; Kumar S; Tjernberg A; Engman L; Rottenberg ME; Holmgren A J Biol Chem; 2013 Sep; 288(38):27456-27468. PubMed ID: 23900839 [TBL] [Abstract][Full Text] [Related]
10. Phenolic Constituents of Medicinal Plants with Activity against Trypanosoma brucei. Sun YN; No JH; Lee GY; Li W; Yang SY; Yang G; Schmidt TJ; Kang JS; Kim YH Molecules; 2016 Apr; 21(4):480. PubMed ID: 27077842 [TBL] [Abstract][Full Text] [Related]
11. The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis. Ettari R; Previti S; Tamborini L; Cullia G; Grasso S; Zappalà M Mini Rev Med Chem; 2016; 16(17):1374-1391. PubMed ID: 27156518 [TBL] [Abstract][Full Text] [Related]
15. Structural analysis and molecular docking of trypanocidal aryloxy-quinones in trypanothione and glutathione reductases: a comparison with biochemical data. Vera B; Vázquez K; Mascayano C; Tapia RA; Espinosa V; Soto-Delgado J; Salas CO; Paulino M J Biomol Struct Dyn; 2017 Jun; 35(8):1785-1803. PubMed ID: 27232454 [TBL] [Abstract][Full Text] [Related]
16. Identification of non-peptidic cysteine reactive fragments as inhibitors of cysteine protease rhodesain. McShan D; Kathman S; Lowe B; Xu Z; Zhan J; Statsyuk A; Ogungbe IV Bioorg Med Chem Lett; 2015 Oct; 25(20):4509-12. PubMed ID: 26342866 [TBL] [Abstract][Full Text] [Related]
17. Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors. Bond CS; Zhang Y; Berriman M; Cunningham ML; Fairlamb AH; Hunter WN Structure; 1999 Jan; 7(1):81-9. PubMed ID: 10368274 [TBL] [Abstract][Full Text] [Related]
18. Benzimidazole inhibitors of the major cysteine protease of Pereira GA; Santos LH; Wang SC; Martins LC; Villela FS; Liao W; Dessoy MA; Dias LC; Andricopulo AD; Costa MA; Nagem RA; Caffrey CR; Liedl KR; Caffarena ER; Ferreira RS Future Med Chem; 2019 Jul; 11(13):1537-1551. PubMed ID: 31469332 [No Abstract] [Full Text] [Related]
19. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness. Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325 [TBL] [Abstract][Full Text] [Related]
20. The discovery of novel antitrypanosomal 4-phenyl-6-(pyridin-3-yl)pyrimidines. Robinson WJ; Taylor AE; Lauga-Cami S; Weaver GW; Arroo RRJ; Kaiser M; Gul S; Kuzikov M; Ellinger B; Singh K; Schirmeister T; Botana A; Eurtivong C; Bhambra AS Eur J Med Chem; 2021 Jan; 209():112871. PubMed ID: 33070078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]